PAX8 and thyroid cancer, nonmedullary, 2: FTC was associated with mutually exclusive mutations in the RAS or PAX8-PPARG fusion oncogenes and lacked the BRAFV600E mutation, which might lead to higher RAI avidity compared to conventional PTC (35).